Hair Loss Mesotherapy — Dermaheal Scalp

Hair loss mesotherapy at Estetika Tábor delivers Dermaheal S. C'rum HL — a pharmaceutical serum containing 56 active substances including peptides, minerals, trace elements, and DHT-blocking compounds — directly into the scalp via microinjection. This bypasses the barrier effect of the scalp skin and places the active agents in direct contact with hair follicles and the dermal papilla, the vascular structure that determines follicle health and hair calibre. The treatment is suitable for clients experiencing excessive hair loss, diffuse thinning, or early-stage alopecia. A minimum course of 5 sessions at 14-day intervals is recommended, repeated twice yearly for ongoing maintenance. Sessions take 30–45 minutes and are performed by a physician.

Hair follicle miniaturisation — the process by which follicles progressively produce finer, shorter, and less pigmented hairs before eventually ceasing production — is driven by a combination of genetic predisposition, DHT (dihydrotestosterone) sensitivity, microcirculation insufficiency, and nutrient deprivation at the follicular level. Dermaheal S. C'rum HL is a Korean-developed mesotherapy compound specifically formulated to address multiple aspects of this process simultaneously. The formulation contains 56 active substances across several functional categories: - **DHT blockers**: prevent androgen-driven follicle shrinkage - **Peptides and growth factors**: stimulate follicle activity and extend the anagen (growth) phase - **Minerals and trace elements**: zinc, biotin precursors, and selenium to support keratin synthesis - **Vasodilators**: improve microcirculation to the dermal papilla, enhancing oxygen and nutrient delivery At Estetika Tábor, the serum is injected into the scalp via fine-needle mesotherapy technique at multiple points distributed across the thinning zones. Sessions take 30–45 minutes including application of topical anaesthetic gel and a brief post-treatment scalp massage to distribute the serum. Physician assessment before the first session establishes the pattern and severity of hair loss, rules out underlying medical causes, and sets appropriate expectations. Results develop over the course of a full 5-session protocol and continue for weeks after the last injection. Studies on mesotherapy for hair loss report improvements in hair density, calibre, and the anagen-to-telogen ratio (the proportion of actively growing versus resting follicles). The treatment is most effective in early-stage androgenetic alopecia and diffuse telogen effluvium rather than late-stage scarring alopecia where follicles are permanently damaged. A maintenance programme of two courses annually (5 sessions each) is typically recommended to sustain improvement. The treatment may be combined with PRP plasma therapy (also available at this clinic) for enhanced follicle biostimulation.